20 November 2017

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

20 November 2017 | n=47

  1. Siefried KJ, Mao L, Cysique LA, Rule J, et al.
    Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive ART.
    AIDS 2017.

  2. Lodi S, Gunthard HF, Dunn D, Garcia F, et al.
    Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.
    AIDS 2017.

  3. Makinson A, Hayot M, Eymard-Duvernay S, Ribet C, et al.
    HIV is associated with airway obstruction: a matched controlled study.
    AIDS 2017.

  4. Mathabire Rucker SC, Tayea A, Bitilinyu-Bangoh J, Bermudez-Aza EH, et al.
    High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients: results from a cross-sectional survey in Malawi.
    AIDS 2017.

  5. Chomont N, Okoye AA, Favre D, Trautmann L, et al.
    Wake me up before you go: A strategy to reduce the latent HIV reservoir.
    AIDS 2017.

  6. Triplette M, Justice A, Attia EF, Tate J, et al.
    Markers of Chronic Obstructive Pulmonary Disease are associated with mortality in people living with HIV.
    AIDS 2017.

  7. Inzaule SC, Hamers RL, Calis J, Boerma R, et al.
    When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children.
    AIDS 2017.

  8. Favarato G, Townsend CL, Bailey H, Peters H, et al.
    Protease inhibitors and preterm delivery: another piece in the puzzle.
    AIDS 2017.

  9. Sharma M, Smith JA, Farquhar C, Ying R, et al.
    Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya: A mathematical modeling analysis.
    AIDS 2017.

  10. Pongpirul W, Pongpirul K, Ananworanich J, Klinbuayaem V, et al.
    Chronic kidney disease incidence and survival of Thai HIV-infected patients.
    AIDS 2017.

  11. Minguez C, Garcia-Deltoro M, Flores J, Galindo MJ, et al.
    Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice.
    AIDS 2017.

  12. Ahmad F, Mishra N, Ahrenstorf G, Franklin BS, et al.
    Evidence of inflammasome activation and formation of monocyte-derived apoptosis-associated speck-like protein containing a caspase-recruitment domain specks in HIV-1 positive patients.
    AIDS 2017.

  13. Vermund SH, Hamilton EL, Griffith S, Jennings L, et al.
    Recruitment of underrepresented minority researchers into HIV prevention research: The HIV Prevention Trials Network (HPTN) Scholars Program.
    AIDS Res Hum Retroviruses 2017.

  14. Toussova O, Kozlov A, Verevochkin S, Lancaster K, et al.
    A Cohort Approach to Real Time Detection of Acute HIV infections among People who Inject Drugs in St. Petersburg, Russia.
    AIDS Res Hum Retroviruses 2017.

  15. Sanders-Beer BE, Voronin Y, McDonald D, Singh A, et al.
    HARNESSING NOVEL IMAGING APPROACHES TO GUIDE HIV PREVENTION AND CURE DISCOVERIES - A NATIONAL INSTITUTES OF HEALTH AND GLOBAL HIV VACCINE ENTERPRISE 2017 MEETING REPORT.
    AIDS Res Hum Retroviruses 2017.

  16. Mendez-Lagares G, Lu D, Merriam D, Baker CA, et al.
    IL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8+ T Cell Responses in Acute Simian Immunodeficiency Virus Infection.
    AIDS Res Hum Retroviruses 2017;33:S81-S92.

  17. Boehm D, Ott M.
    Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.
    AIDS Res Hum Retroviruses 2017;33:S8-S22.

  18. Christensen-Quick A, Vanpouille C, Lisco A, Gianella S, et al.
    Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.
    AIDS Res Hum Retroviruses 2017;33:S23-S30.

  19. Paules CI, Eisinger RW, Marston HD, Fauci AS, et al.
    What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats.
    Ann Intern Med 2017.

  20. Wong C, Gange SJ, Moore RD, Justice AC, et al.
    Multimorbidity Among Persons Living with HIV in the U.S.
    Clin Infect Dis 2017.

  21. Bedimo RJ, Adams-Huet B, Poindexter J, Brown G, et al.
    The Differential Effects of HIV and HCV on Bone Micro-Architecture and Fracture risk.
    Clin Infect Dis 2017.

  22. Veit O, Domingo C, Niedrig M, Staehelin C, et al.
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis 2017.

  23. Maheswaran H, Clarke A, MacPherson P, Kumwenda F, et al.
    Cost-effectiveness of community-based HIV self-testing in Blantyre, Malawi.
    Clin Infect Dis 2017.

  24. McDonald CR, Conroy AL, Gamble JL, Papp E, et al.
    Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
    Clin Infect Dis 2017.

  25. Erlandson KM, Lake JE, Sim M, Falutz J, et al.
    Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared to Men.
    J Acquir Immune Defic Syndr 2017.

  26. Farhadian S, Jalbert E, Deng Y, Goetz MB, et al.
    HIV and Age Do Not Synergistically Affect Age-Related T cell Markers.
    J Acquir Immune Defic Syndr 2017.

  27. Kay ES, Rice WS, Crockett KB, Atkins GC, et al.
    Experienced Hiv-Related Stigma in Healthcare and Community Settings: Mediated Associations With Psychosocial and Health Outcomes.
    J Acquir Immune Defic Syndr 2017.

  28. Golub SA, Lelutiu-Weinberger C, Surace A.
    An Experimental Investigation of Implicit Hiv And Prep Stigma: Evidence For Ancillary Benefits of Prep Use.
    J Acquir Immune Defic Syndr 2017.

  29. Mmbaga EJ, Moen K, Leyna GH, Mpembeni R, et al.
    Hiv Prevalence and Associated Risk Factors Among Men Who Have Sex With Men in Dar Es Salaam, Tanzania.
    J Acquir Immune Defic Syndr 2017.

  30. Mugwanya KK, Baeten JM, Wyatt C, Mugo NR, et al.
    Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr 2017.

  31. Nakiwala JK, Walker NF, Diedrich CR, Worodria W, et al.
    Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome.
    J Acquir Immune Defic Syndr 2017.

  32. Stevens ER, Nucifora K, Zhou Q, Braithwaite RS, et al.
    Cost-Effectiveness Of Peer- Versus Venue-Based Approaches For Detecting Undiagnosed Hiv Among Heterosexuals In High-Risk New York City Neighborhoods.
    J Acquir Immune Defic Syndr 2017.

  33. Gunaratnam P, McManus H, Watchirs-Smith L, McGregor S, et al.
    People Born In Non-Main English Speaking Countries Are Less Likely To Start Hiv Treatment Early In Australia: A National Cohort Analysis, 2014-15.
    J Acquir Immune Defic Syndr 2017.

  34. Morgan E, Skaathun B, Duvoisin R, Michaels S, et al.
    Are Hiv Seroconversions Among Young Men Who Have Sex With Men Associated With Social Network Proximity To Recently Or Long-Term Hiv-Infected Individuals?
    J Acquir Immune Defic Syndr 2017.

  35. Robinson JA, Marzinke MA, Fuchs EJ, Bakshi RP, et al.
    Comparison Of The Pharmacokinetics And Pharmacodynamics Of Single-Dose Tenofovir Vaginal Film And Gel Formulation (Fame-05).
    J Acquir Immune Defic Syndr 2017.

  36. Logie CH, Lacombe-Duncan A, Wang Y, Kaida A, et al.
    Pathways from Hiv-Related Stigma to Antiretroviral Therapy Measures in The Hiv Care Cascade for Women Living with Hiv in Canada.
    J Acquir Immune Defic Syndr 2017.

  37. Yen YF, Lan YC, Huang CT, Jen IA, et al.
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-Based Cohort Study in Taiwan.
    J Infect Dis 2017;216:1000-1007.

  38. Huang YA, Tao G, Samandari T, Hoover KW, et al.
    Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    J Infect Dis 2017.

  39. Steba GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al.
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis 2017.

  40. Chaillon A, Gianella S, Lada SM, Perez-Santiago J, et al.
    Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
    J Virol 2017.

  41. White E, Wu F, Chertova E, Bess J, et al.
    Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions.
    J Virol 2017.

  42. Yoon CH, Kim SY, Byeon SE, Jeong Y, et al.
    Correction for Yoon et al., "p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation".
    J Virol 2017;91.

  43. Dehority W, Viani RM, Araneta MRG, Lopez G, et al.
    Comparison of the QuantiFERON TB Gold In-tube Assay With Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection Among HIV-infected and Uninfected Children.
    Pediatr Infect Dis J 2017;36:e317-e321.

  44. Succi RC, Krauss MR, Harris DR, Machado DM, et al.
    Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
    Pediatr Infect Dis J 2017.

  45. Mandalakas AM, Highsmith HY, Harris NM, Pawlicka A, et al.
    T-SPOT.TB(R) Performance in Routine Pediatric Practice in a Low TB Burden Setting.
    Pediatr Infect Dis J 2017.

  46. Corrigan B, Mukui I, Mulenga L, Mthethwa N, et al.
    Characteristics of Treatment-Experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment.
    Pediatr Infect Dis J 2017.

  47. Liu Y, Chen J, Nikolaitchik OA, Desimmie BA, et al.
    The roles of five conserved lentiviral RNA structures in HIV-1 replication.
    Virology 2017;514:1-8.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

20 November 2017

13 November 2017

06 November 2017

30 October 2017

23 October 2017


20 November 2017

Multidisciplinary Journal Club

  1. Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, et al.
    Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
    JAMA. 2017;318:1679-1686.

  2. Churchyard G, Kim P, Shah NS, Rustomjee R, et al.
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.

  3. Belknap R, Holland D, Feng PJ, Millet JP, et al.
    Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
    Ann Intern Med. 2017 Nov 7. doi: 10.7326/M17-1150.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016